Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label First and Only RNA-targeted Prophylactic Treatment. Show all posts
Showing posts with label First and Only RNA-targeted Prophylactic Treatment. Show all posts
Monday, January 5, 2026

FDA Approves Dawnzera (donidalorsen) as the First and Only RNA-targeted Prophylactic Treatment for Hereditary Angioedema

›
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced the U.S. Food and Drug Administration (FDA) approval of Dawnzera (donidalorsen) for pro...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.